MicroRNAs that respond to histone deacetylase inhibitor SAHA and p53 in HCT116 human colon carcinoma cells

被引:37
作者
Shin, Sangsu [1 ]
Lee, Eun-Mee [1 ]
Cha, Hwa Jun [1 ]
Bae, Seunghee [1 ]
Jung, Jin Hyuk [1 ]
Lee, Sun-Mi [1 ]
Yoon, Youngmin [1 ]
Lee, Hyunjin [1 ]
Kim, Sumi [1 ]
Kim, Hyunsook [1 ]
Lee, Su-Jae [2 ]
Park, In-Chul [3 ]
Jin, Young-Woo [4 ]
An, Sungkwan [1 ,5 ]
机构
[1] Konkuk Univ, Funct Genoproteome Res Ctr, Seoul 143701, South Korea
[2] Hanyang Univ, Dept Chem, Seoul 133791, South Korea
[3] Korea Inst Radiol & Med Sci, Lab Funct Genom, Seoul 139706, South Korea
[4] Radiat Hlth Res Inst KHNP, Div Radiat Effect Res, Seoul 132703, South Korea
[5] LIFEnGENE Inc, Seoul 143701, South Korea
关键词
microRNA; histone deacetylase inhibitor; SAHA; p53; HCT116; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CANCER; ACETYLATION; APOPTOSIS; ACETYLTRANSFERASES; DIFFERENTIATION; INDUCTION; MECHANISM; THERAPY;
D O I
10.3892/ijo_00000452
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (rniRNAs) are important post-transcriptional regulators involved in many biological processes. We investigated the expression profiles of rniRNAs affected by the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), and p53 in the human colon cancer cell line, HCT116 (wt-p53) and its derivative, HCT116 (null-p53). In a microarray assay, 144 of 275 human rniRNAs showed several-fold changes in transcription. Most of these rniRNAs were strongly affected by SAHA, and their expression profiles varied depending on the presence of p53. Thirty-one miRNAs showing the greatest expression changes were selected for target prediction, and genes related to apoptosis (102), cell cycle (38), and differentiation (102) were predicted. Each miRNA had many target genes, and several genes also were targeted by many rniRNAs. Putative p53 upstream binding sites for the miRNAs were determined, and most sites scored >85%, suggesting a high probability of binding. In conclusion, we identified several miRNAs whose expression was affected by both SAHA and p53. Many of the miRNAs showed dramatic changes and were predicted to target many mRNAs. Further studies will be needed to verify these predictions.
引用
收藏
页码:1343 / 1352
页数:10
相关论文
共 40 条
[1]   MicroRNA functions in animal development and human disease [J].
Alvarez-Garcia, I ;
Miska, EA .
DEVELOPMENT, 2005, 132 (21) :4653-4662
[2]   Role for a bidentate ribonuclease in the initiation step of RNA interference [J].
Bernstein, E ;
Caudy, AA ;
Hammond, SM ;
Hannon, GJ .
NATURE, 2001, 409 (6818) :363-366
[3]   Anticancer activities of histone deacetylase inhibitors [J].
Bolden, Jessica E. ;
Peart, Melissa J. ;
Johnstone, Ricky W. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (09) :769-784
[4]   Regulation of activity of the transcription factor GATA-1 by acetylation [J].
Boyes, J ;
Byfield, P ;
Nakatani, Y ;
Ogryzko, V .
NATURE, 1998, 396 (6711) :594-598
[5]   The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin [J].
Butler, LM ;
Zhou, XB ;
Xu, WS ;
Scher, HI ;
Rifkind, RA ;
Marks, PA ;
Richon, VM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11700-11705
[6]   Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis [J].
Chang, Tsung-Cheng ;
Wentzel, Erik A. ;
Kent, Oliver A. ;
Ramachandran, Kalyani ;
Mullendore, Michael ;
Lee, Kwang Hyuck ;
Feldmann, Georg ;
Yamakuchi, Munekazu ;
Ferlito, Marcella ;
Lowenstein, Charles J. ;
Arking, Dan E. ;
Beer, Michael A. ;
Maitra, Anirban ;
Mendell, Joshua T. .
MOLECULAR CELL, 2007, 26 (05) :745-752
[7]   Histone deacetylase 3 binds to and regulates the GCMa transcription factor [J].
Chuang, HC ;
Chang, CW ;
Chang, GD ;
Yao, TP ;
Chen, HW .
NUCLEIC ACIDS RESEARCH, 2006, 34 (05) :1459-1469
[8]   Processing of primary microRNAs by the Microprocessor complex [J].
Denli, AM ;
Tops, BBJ ;
Plasterk, RHA ;
Ketting, RF ;
Hannon, GJ .
NATURE, 2004, 432 (7014) :231-235
[9]   Clinical development of histone deacetylase inhibitors as anticancer agents [J].
Drummond, DC ;
Noble, CO ;
Kirpotin, DB ;
Guo, ZX ;
Scott, GK ;
Benz, CC .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 :495-528
[10]   Suberoylanilide hydroxamic acid (SAHA) has potent anti-glioma properties in vitro, ex vivo and in vivo [J].
Eyüpoglu, IY ;
Hahnen, E ;
Buslei, R ;
Siebzehnrübl, FA ;
Savaskan, NE ;
Lüders, M ;
Tränkle, C ;
Wick, W ;
Weller, M ;
Fahlbusch, R ;
Blümcke, I .
JOURNAL OF NEUROCHEMISTRY, 2005, 93 (04) :992-999